Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

LSTA

LSTA News

Newswire

19:49

Lisata Therapeutics Prepares for Milestone-Rich 2026 with Expanded Alliances and Phase III Certepetide Trial Plans

16:43

Lisata Therapeutics Advances Certepetide and Forms Strategic Alliances in Q3

15:33

Lisata Therapeutics Wins 'Overall BioPharma Solution of the Year' Award for CendR Platform

08:35

Lisata Therapeutics wins "Overall BioPharma Solution of the Year" award.

16:19

Lisata Therapeutics shares surge 19.31% after-hours on positive preclinical data showing certepetide enhances ADC efficacy and tumor penetration.

View More

About LSTA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More